Medicine and Dentistry
Antibiotic Therapy
15%
Antibiotics
17%
Antibodies
19%
Bacteremia
14%
Beta Hemolytic Streptococcus
19%
Blood Culture
26%
Body Mass Index
18%
Borrelia
12%
Borrelia burgdorferi
23%
Borreliella
27%
C Reactive Protein
19%
Cerebrospinal Fluid
31%
Chronic Obstructive Pulmonary Disease
38%
Cohort Analysis
84%
Cohort Study
12%
COVID-19
28%
Creatinine
25%
Diagnosis
34%
Disability Pension
12%
Disease
23%
Emergency Department
19%
Hazard Ratio
17%
Hip Replacement
19%
Infection
75%
Kidney Injury
20%
Knee Replacement
14%
Laboratory Test
13%
Long Term Survival
19%
Lyme Borreliosis
59%
Lyme Neuroborreliosis
50%
Meningitis
13%
Odds Ratio
17%
Outpatient
14%
Pneumococcal Infection
28%
Polymerase Chain Reaction
34%
Polymerase Chain Reaction
21%
Population
21%
Prospective Cohort Study
12%
Public Health
14%
Retrospective Study
30%
Rickettsia
16%
Serum Albumin
19%
Severe Acute Respiratory Syndrome Coronavirus 2
31%
Social Interaction
19%
SOFA Score
16%
Staphylococcus Aureus
20%
Streptococcus Group A
12%
Symptom
19%
Tick Bite
13%
Varicella Zoster Virus
19%
Immunology and Microbiology
Anaerobic Bacterium
19%
Blood Plasma
19%
Borrelia
32%
Borrelia burgdorferi
52%
Borrelia miyamotoi
14%
Borreliella
53%
Brain Tissue
19%
C-Reactive Protein
19%
Cerebrospinal Fluid
24%
Clinical Microbiology
24%
Comorbidity
22%
COVID-19
20%
Dynamics
11%
ELISA
24%
Enzyme-Linked Immunosorbent Assay
19%
Escherichia coli
27%
Flagellum
16%
Fusobacterium
14%
Human Respiratory Syncytial Virus
14%
Immunoglobulin G Antibody
34%
Immunoglobulin M
54%
Immunoglobulin M Antibody
31%
Klebsiella pneumoniae
14%
Laboratory Test
20%
Lower Respiratory Tract
12%
Meningitis
13%
Microbiology
33%
Microorganism
21%
Monospecific Antibody
100%
Multiple Sclerosis
19%
Myeloid
13%
Polymerase Chain Reaction
43%
Polymerase Chain Reaction
11%
Prevalence
20%
Psoriatic Arthritis
11%
Real Time Polymerase Chain Reaction
23%
Recombinant Antigen
14%
Seroconversion
17%
Serology
18%
Seroprevalence
11%
Serotype
10%
Severe Acute Respiratory Syndrome Coronavirus 2
25%
Single Nucleotide Polymorphism
11%
Staphylococcus Aureus
32%
Streptococcus
11%
Streptococcus Group A
11%
Systemic Inflammatory Response Syndrome
19%
Tumor Necrosis Factor
15%
Vaccine Efficacy
12%
Western Blot
11%
Pharmacology, Toxicology and Pharmaceutical Science
Ampicillin
10%
Antibiotic Therapy
10%
Antiinfective Agent
10%
Bacteremia
20%
Bacterial Meningitis
9%
Beta Hemolytic Streptococcus
19%
Beta Lactamase
9%
Borrelia burgdorferi
10%
Borreliella
10%
Brain Edema
9%
C Reactive Protein
9%
Central Nervous System Infection
9%
Chlamydiae
9%
Chlamydiasis
9%
Chronic Obstructive Lung Disease
57%
Cohort Study
94%
Colorectal Cancer
19%
Comorbidity
10%
Coronavirinae
12%
Creatinine
19%
Delta Variant
9%
Disease
22%
Epileptic Absence
19%
Erythromycin
9%
Fusobacterium
10%
Haemophilus influenzae
19%
Herpes Simplex Virus 2
9%
Human Alphaherpesvirus 1
9%
Infection
53%
Kidney Injury
14%
Lower Respiratory Tract Infection
11%
Meningitis
12%
Pelvic Inflammatory Disease
9%
Penicillin Derivative
11%
Pneumococcal Infection
29%
Pneumococcus Vaccine
9%
Prevalence
11%
Prospective Cohort Study
10%
Pseudomonas aeruginosa
11%
Reinfection
10%
RNA 18S
9%
SARS Coronavirus
23%
Staphylococcus Aureus
14%
Stenotrophomonas maltophilia
9%
Streptococcus Group A
12%
Streptococcus Pneumoniae
16%
Streptococcus pyogenes
9%
Sulfamethizole
9%
Urinary Tract Infection
9%
Vaccination Policy
24%
